Objective: This study aimed to develop and validate a predictive model for differentiating central from peripheral etiologies in patients with isolated vestibular syndrome (VS). Methods: In this multicenter retrospective cohort study, 506 patients with isolated VS from five hospitals were divided into derivation ( n = 301) and validation ( n = 205) cohorts. Multivariable logistic regression was performed to determine independent predictors of central VS. These predictors were assigned weights to construct the SAV 3 E score. The performance of the SAV 3 E was assessed using the area under the curve (AUC), calibration, and decision curve analysis (DCA) and compared with that of the TriAGe+ and STANDING models. Results: The SAV 3 E score incorporated five predictors: absence of vestibular vagal symptoms (OR, 0.233; 95% CI, 0.084–0.648; p = 0.005), prior stroke (OR, 15.204; 95% CI, 4.455–51.884; p < 0.001), ABCD 2 score of 4–7 (OR, 1.903; 95% CI, 1.206–3.004; p = 0.006), central video oculography nystagmus (OR, 38.377; 95% CI, 8.631–170.644; p < 0.001), and positive video head impulse test (OR, 0.078; 95% CI, 0.033–0.188; p < 0.001). It displayed good discriminative performance with AUCs 0.910 and 0.886 in the derivation and validation cohorts, respectively. It outperformed TriAGe+ (AUC: 0.706) and STANDING (AUC: 0.779) models. Furthermore, calibration analysis revealed good model fit across cohorts (Hosmer‐Lemeshow test results: derivation cohort, p = 0.899; validation cohort, p = 0.789). DCA confirmed good clinical utility across a wide range of probability thresholds (derivation cohort: 0.01–0.86, validation cohort: 0.01–1.00). Conclusion: The SAV 3 E score is a validated tool aimed at differentiating central versus peripheral VS, with the potential to improve diagnostic accuracy for urgent etiologies such as stroke.